NCT01662921 - Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

August 31, 2015

Conditions

Diabetes During Pregnancy

Interventions

DRUG

NPH

Long acting insulin NPH dosing will be titrated weekly derived from the patients current weight and gestational age

DRUG

Insulin LISPRO

Insulin lispro dosing will be titrated weekly based on the patient's average SMBG readings from each meal during the past three days

DRUG

Insulin glulisine

Insulin glulisine will be titrated weekly based on the patient's average SMBG readings from each meal during the past three days

Trial Locations (1)

William Sansum Diabetes Center, Santa Barbara